SeeThruEquity, a leading investment research and corporate access firm focused on public smallcap and microcap companies, is hosting its Fall Smallcap and Microcap Investor Conference on October 2 and 3, 2012 at the Cornell Club in midtown Manhattan. Registration will begin at 7:45AM on October 2 and will run from 8am to 5pm on October 2 and 12pm to 5pm on October 3.

Senior management from a select group of companies will make presentations about their respective businesses to an elite group of institutional and retail investors, equity analysts and industry professionals. 1-on-1 meetings between qualified investors and the presenting companies will also be arranged by appointment.

Presenting companies to include:

Applied DNA Sciences Inc.   OTCBB: APDN Bovie Medical Corp   NYSE: BVX China Digital TV Holding Co  

NYSE: STV

diaDexus, Inc  

OTC: DDXS

International Stem Cell Corp  

OTC: ISCO

Inuvo, Inc.  

NYSE: INUV

Mac-Gray Corp  

NYSE: TUC

Perma-Fix Environmental Services Inc.  

NASDAQ: PESI

Quadrant 4 Systems Corp  

OTC: QFOR

SoundBite Communications, Inc.   NASDAQ: SDBT The Cash Store Financial Services, Inc.  

NYSE: CSFS

Qualified investors and equity research analysts may attend the conference without charge and other interested parties may join the conference for a $149 fee. Please visit SeeThruEquity Fall Conference Home Page for more information about the conference.

You may register for the conference by clicking SeeThruEquity Fall Conference Attendee Registration.

About SeeThruEquity, LLC

SeeThruEquity, LLC is an investment research and corporate access firm that produces high quality research reports on smallcap and microcap companies with less than $1 billion in market capitalization. The traditional Wall Street analyst establishment has typically underserved these companies. We are unfettered by any ties to investment banking or trading, and distribute our high impact research as an approved firm for consensus estimates on Thomson Reuters, CapitalIQ, FactSet, Zacks and StockTwits, as well as to our own audience of investors from our corporate website.

Our philosophy is focused on delivering an unbiased, institutional quality research product for such uncovered or undercovered companies to all levels of investors in the investment community and at absolutely no charge to the reader of the research or the company being covered. We seek to build relationships between corporate issuers and institutional and sophisticated investors via compelling investor conferences and forums as well as non-deal road shows.

Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Applied DNA Sciences Charts.
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Applied DNA Sciences Charts.